中外健康文摘
中外健康文摘
중외건강문적
WORLD HEALTH DIGEST
2013年
42期
43-44
,共2页
中心静脉导管引流%顺铂%沙培林%肺癌%胸腔积液
中心靜脈導管引流%順鉑%沙培林%肺癌%胸腔積液
중심정맥도관인류%순박%사배림%폐암%흉강적액
目的:探讨中心静脉导管引流并胸腔内注射顺铂和沙培林治疗肺癌合并胸腔积液患者的临床疗效。方法:选取我院在2010年1月至2012年12月收治的肺癌合并胸腔积液患者40例,观察组于胸腔内注射顺铂和沙培林治疗,对照组给予顺铂治疗。结果:观察组有效率(85.0%)明显大于对照组(65.0%), P<0.05;两组毒副反应均较轻微,毒副反应发生率的比较无明显差异P>0.05。结论:对合并胸腔积液的肺癌患者行中心静脉导管引流并胸腔内注射顺铂和沙培林治疗的效果显著,值得临床推广。
目的:探討中心靜脈導管引流併胸腔內註射順鉑和沙培林治療肺癌閤併胸腔積液患者的臨床療效。方法:選取我院在2010年1月至2012年12月收治的肺癌閤併胸腔積液患者40例,觀察組于胸腔內註射順鉑和沙培林治療,對照組給予順鉑治療。結果:觀察組有效率(85.0%)明顯大于對照組(65.0%), P<0.05;兩組毒副反應均較輕微,毒副反應髮生率的比較無明顯差異P>0.05。結論:對閤併胸腔積液的肺癌患者行中心靜脈導管引流併胸腔內註射順鉑和沙培林治療的效果顯著,值得臨床推廣。
목적:탐토중심정맥도관인류병흉강내주사순박화사배림치료폐암합병흉강적액환자적림상료효。방법:선취아원재2010년1월지2012년12월수치적폐암합병흉강적액환자40례,관찰조우흉강내주사순박화사배림치료,대조조급여순박치료。결과:관찰조유효솔(85.0%)명현대우대조조(65.0%), P<0.05;량조독부반응균교경미,독부반응발생솔적비교무명현차이P>0.05。결론:대합병흉강적액적폐암환자행중심정맥도관인류병흉강내주사순박화사배림치료적효과현저,치득림상추엄。
objective: to study the central venous catheter drainage and chest cavity injection of cisplatin and the patient's clinical curative effect of 36 patients with lung cancer merger pleural effusion tredted by streptococcus. Selection methods: our hospital in January 2010 to December 2012 were analyzed in 40 patients with lung cancer merger pleural effusion, the observation group in the chest cavity injection of cisplatin and ShaPeiLin treatment, control group given cisplatin treatment. Results: the observation group efficiency (85.0%) were significantly greater than the control group (65.0%), P < 0.05; Two groups of adverse reactions are mild, the incidence of adverse reaction was no significant difference (P>0.05) Conclusion: the combined central venous catheter drainage of pleural effusion of lung cancer patients and chest cavity injection of cisplatin and ShaPeiLin treatment effect is remarkable, worth clinical promotion.